These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2029490)

  • 1. Varying susceptibility of different low density lipoproteins to oxidative modification.
    Jialal I; Freeman DA; Grundy SM
    Arterioscler Thromb; 1991; 11(3):482-8. PubMed ID: 2029490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary gas chromatography quantification of cholesterol in copper-oxidized low-density lipoprotein.
    Tanaka M; Kanamaru S
    Biol Pharm Bull; 1993 Jun; 16(6):538-43. PubMed ID: 8364505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits.
    Vine DF; Mamo CL; Beilin LJ; Mori TA; Croft KD
    J Lipid Res; 1998 Oct; 39(10):1995-2004. PubMed ID: 9788246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
    Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THP1 macrophages oxidized cholesterol, generating 7-derivative oxysterols specifically released by HDL.
    Chen Y; Arnal-Levron M; Lagarde M; Moulin P; Luquain-Costaz C; Delton I
    Steroids; 2015 Jul; 99(Pt B):212-8. PubMed ID: 25742736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
    Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
    Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages.
    Brown AJ; Dean RT; Jessup W
    J Lipid Res; 1996 Feb; 37(2):320-35. PubMed ID: 9026530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL.
    Fuhrman B; Judith O; Keidar S; Ben-Yaish L; Kaplan M; Aviram M
    Free Radic Biol Med; 1997; 23(1):34-46. PubMed ID: 9165295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein.
    Dzeletovic S; Babiker A; Lund E; Diczfalusy U
    Chem Phys Lipids; 1995 Nov; 78(2):119-28. PubMed ID: 8565112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
    Chait A; Brazg RL; Tribble DL; Krauss RM
    Am J Med; 1993 Apr; 94(4):350-6. PubMed ID: 8475928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis(monoacylglycero)phosphate reduces oxysterol formation and apoptosis in macrophages exposed to oxidized LDL.
    Arnal-Levron M; Chen Y; Delton-Vandenbroucke I; Luquain-Costaz C
    Biochem Pharmacol; 2013 Jul; 86(1):115-21. PubMed ID: 23542536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major differences in oxysterol formation in human low density lipoproteins (LDLs) oxidized by *OH/O2*- free radicals or by copper.
    Zarev S; Thérond P; Bonnefont-Rousselot D; Beaudeux JL; Gardès-Albert M; Legrand A
    FEBS Lett; 1999 May; 451(2):103-8. PubMed ID: 10371147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1.
    Terasaka N; Wang N; Yvan-Charvet L; Tall AR
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15093-8. PubMed ID: 17846428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
    Hussein O; Schlezinger S; Rosenblat M; Keidar S; Aviram M
    Atherosclerosis; 1997 Jan; 128(1):11-8. PubMed ID: 9051193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of human LDL by in vitro incubation with cigarette smoke or copper ions: implications for allergies, asthma and atherosclerosis.
    Vruwink KG; Gershwin ME; Sachet P; Halpern G; Davis PA
    J Investig Allergol Clin Immunol; 1996; 6(5):294-300. PubMed ID: 8959540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.